These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 21351147)

  • 21. Hip fracture mortality and morbidity--can we do better?
    Davidson CW; Merrilees MJ; Wilkinson TJ; McKie JS; Gilchrist NL
    N Z Med J; 2001 Jul; 114(1136):329-32. PubMed ID: 11548098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of vitamin D inadequacy in osteoporotic hip fracture patients in London.
    Moniz C; Dew T; Dixon T
    Curr Med Res Opin; 2005 Dec; 21(12):1891-4. PubMed ID: 16368037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Osteoporosis pharmacotherapy and counseling services in US ambulatory care clinics: opportunities for multidisciplinary interventions.
    Teschemaker A; Lee E; Xue Z; Wutoh AK
    Am J Geriatr Pharmacother; 2008 Dec; 6(5):240-8. PubMed ID: 19161926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physician and patient perceptions on the use of vitamin D and calcium in osteoporosis treatment: a European and Latin American perspective.
    Resch H; Walliser J; Phillips S; Wehren LE; Sen SS
    Curr Med Res Opin; 2007 Jun; 23(6):1227-37. PubMed ID: 17559732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of calcium supplements, vitamin D supplements and specific osteoporosis drugs among French women aged 75-85 years: patterns of use and associated factors.
    Castro-Lionard K; Dargent-Molina P; Fermanian C; Gonthier R; Cassou B
    Drugs Aging; 2013 Dec; 30(12):1029-38. PubMed ID: 24114665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Undertreatment of osteoporosis in regional Western Australia.
    Lai MM; Ang WM; McGuiness M; Larke AB
    Australas J Ageing; 2012 Jun; 31(2):110-4. PubMed ID: 22676170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The epidemiology of hip fractures and methods of prevention.
    Armstrong AL; Wallace WA
    Acta Orthop Belg; 1994; 60 Suppl 1():85-101. PubMed ID: 8053345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk-adjusted mortality rates of elderly veterans with hip fractures.
    Bass E; French DD; Bradham DD; Rubenstein LZ
    Ann Epidemiol; 2007 Jul; 17(7):514-9. PubMed ID: 17420142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Older adults' medication use 6 months before and after hip fracture: a population-based cohort study.
    Kragh A; Elmståhl S; Atroshi I
    J Am Geriatr Soc; 2011 May; 59(5):863-8. PubMed ID: 21517788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-Osteoporosis Medications Associated with Decreased Mortality after Hip Fracture.
    Wang PW; Li YZ; Zhuang HF; Yu HM; Cai SQ; Xu H; Chen ZH; Lin JK; Yao XD
    Orthop Surg; 2019 Oct; 11(5):777-783. PubMed ID: 31429532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of osteoporotic treatment on the functional outcome, re-fracture rate, quality of life and mortality in patients with hip fractures: a prospective functional and clinical outcome study on 520 patients.
    Makridis KG; Karachalios T; Kontogeorgakos VA; Badras LS; Malizos KN
    Injury; 2015 Feb; 46(2):378-83. PubMed ID: 25541417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can vitamin D supplementation reduce the risk of fracture in the elderly? A randomized controlled trial.
    Meyer HE; Smedshaug GB; Kvaavik E; Falch JA; Tverdal A; Pedersen JI
    J Bone Miner Res; 2002 Apr; 17(4):709-15. PubMed ID: 11918228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Access to Anti-osteoporosis Medication after Hip Fracture in Korean Elderly Patients.
    Yu YM; Lee JY; Lee E
    Maturitas; 2017 Sep; 103():54-59. PubMed ID: 28778333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of in-hospital management of fracture risk in older patients: a chart review study of tertiary prevention.
    Byszewski AM; Cranney A; Man-Son-Hing M; Azad N; Amos S
    Arch Gerontol Geriatr; 2006; 42(3):319-28. PubMed ID: 16213039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of hip protectors in the prevention of osteoporosis related hip fractures in elderly nursing home residents.
    Singh S; Sun H; Anis AH
    J Rheumatol; 2004 Aug; 31(8):1607-13. PubMed ID: 15290742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical risk factors for recurrent fracture after hip fracture: a prospective study.
    Colón-Emeric CS; Lyles KW; Su G; Pieper CF; Magaziner JS; Adachi JD; Bucci-Rechtweg CM; Haentjens P; Boonen S;
    Calcif Tissue Int; 2011 May; 88(5):425-31. PubMed ID: 21331567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Need for additional calcium to reduce the risk of hip fracture with vitamin d supplementation: evidence from a comparative metaanalysis of randomized controlled trials.
    Boonen S; Lips P; Bouillon R; Bischoff-Ferrari HA; Vanderschueren D; Haentjens P
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1415-23. PubMed ID: 17264183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Are calcium and vitamin D supplements for everyone?: Pro].
    García Vadillo JA
    Reumatol Clin; 2011 Sep; 7 Suppl 2():S34-9. PubMed ID: 21924218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of subsidizing effective anti-osteoporosis drugs on compliance with management guidelines in patients following low-impact fractures.
    Liel Y; Castel H; Bonneh DY
    Osteoporos Int; 2003 Jul; 14(6):490-5. PubMed ID: 12730761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Do patients receive recommended treatment of osteoporosis following hip fracture in primary care?
    Petrella RJ; Jones TJ
    BMC Fam Pract; 2006 May; 7():31. PubMed ID: 16684358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.